Health: Neurology News

Today is September 11, 2024. All times in Eastern Daylight Time.

Ncardia lanceert een reeks kant-en-klare testen om de screening en selectie van nieuwe therapeutische kandidaten te stroomlijnen

09/10/2024 - 04:16 PM

BUSINESS WIRE
Ncardia lance un panel de tests prêts à l'emploi pour simplifier le processus de dépistage et de sélection de nouveaux candidats thérapeutiques

09/10/2024 - 04:15 PM

BUSINESS WIRE
Positive Daten zur Niemann-Pick-Krankheit Typ C (NPC) und GM2-Gangliosidose aus der von Azafaros durchgeführten Phase-2-RAINBOW-Studie mit Nizubaglustat werden auf einer großen Konferenz über Stoffwechselkrankheiten vorgestellt

09/10/2024 - 01:50 PM

BUSINESS WIRE
Samenvatting: Tijdens een belangrijke conferentie over stofwisselingsziekten werden positieve gegevens voorgesteld over de ziekte van Niemann-Pick type C (NPC) en GM2-gangliosidose uit de nizubaglustat Fase 2 RAINBOW-studie gevoerd door Azafaros

09/10/2024 - 01:50 PM

BUSINESS WIRE
Riassunto: Presentati a un'importante conferenza sulle malattie metaboliche dati positivi sulla malattia di Niemann-Pick di tipo C (NPC) e sulla gangliosidosi-GM2 rilevati dallo studio RAINBOW di fase 2 su nizubaglustat, condotto da Azafaros

09/10/2024 - 01:50 PM

BUSINESS WIRE
Resumen: Se presentan datos positivos sobre la enfermedad de Niemann-Pick tipo C (NPC) y la gangliosidosis GM2 del estudio de fase 2 RAINBOW de nizubaglustat realizado por Azafaros en un importante congreso sobre enfermedades metabólicas

09/10/2024 - 01:50 PM

BUSINESS WIRE
Des données positives sur la maladie de Niemann-Pick de type C (NPC) et la gangliosidose GM2 issues de l’étude RAINBOW de phase 2 sur le nizubaglustat menée par Azafaros présentées lors d’une importante conférence sur les maladies métaboliques

09/10/2024 - 01:50 PM

BUSINESS WIRE
Variscite and Peridio Partner to Accelerate Development of Edge AI Devices

09/10/2024 - 11:46 AM

BUSINESS WIRE
Global Brain-Computer Interfaces Markets 2025-2035: Signal Acquisition Methods and Neural Interfaces - Revolutionizing Neuroprosthetics and Rehabilitation - ResearchAndMarkets.com

09/10/2024 - 09:14 AM

BUSINESS WIRE
Inflammasome Therapeutics Completes Enrollment in Study for First Oral Dual Inflammasome Inhibitor for Ophthalmic and Neuroinflammatory Diseases

09/10/2024 - 08:55 AM

BUSINESS WIRE
Marinus Pharmaceuticals to Present at the 2024 Cantor Global Healthcare Conference

09/10/2024 - 08:00 AM

BUSINESS WIRE
Ncardia Launches Panel of Ready-to-Use Assays to Streamline Screening and Selection of New Therapeutic Candidates

09/10/2024 - 07:00 AM

BUSINESS WIRE
Positive Niemann-Pick disease type C (NPC) and GM2 gangliosidosis data from nizubaglustat Phase 2 RAINBOW study conducted by Azafaros presented at major metabolic disease conference

09/10/2024 - 03:00 AM

BUSINESS WIRE
MindMed Announces New Employee Inducement Grants

09/09/2024 - 04:01 PM

BUSINESS WIRE
Wharton Neuroscience and RMT Partner to Help Brands Grow and Advance Science

09/09/2024 - 09:00 AM

BUSINESS WIRE

1 2 3 4 5 6 7 8

Next »

Search